iNfarcTion) Echocardiographic Study Myocardial Infarction: The VALIANT (VALsartan In Acute myocardial Prognostic Implications of Left Ventricular Mass and Geometry Following

[1]  S. Pede,et al.  Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. , 2006, American journal of hypertension.

[2]  C. Lavie,et al.  Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. , 2006, The American journal of cardiology.

[3]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[4]  S. Solomon,et al.  Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction , 2005, Circulation.

[5]  E. Benjamin,et al.  Left Ventricular Mass Indexed to Height and Prevalent MRI Cerebrovascular Disease in an African American Cohort: The Atherosclerotic Risk in Communities Study , 2005, Stroke.

[6]  T. Kahan,et al.  Left ventricular hypertrophy in hypertension: its arrhythmogenic potential , 2005, Heart.

[7]  S. Pede,et al.  Regression of Left Ventricular Hypertrophy and Prevention of Stroke in Hypertensive Subjects: 2.13 , 2005 .

[8]  D. Rizzoni,et al.  Left Ventricular Concentric Geometry During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients , 2004, Hypertension.

[9]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[10]  Shunichi Homma,et al.  Left Ventricular Mass and Geometry and the Risk of Ischemic Stroke , 2003, Stroke.

[11]  G. de Simone,et al.  Prognosis of Inappropriate Left Ventricular Mass in Hypertension: The MAVI Study , 2002, Hypertension.

[12]  J. Laragh,et al.  Myocardial function and geometry in hypertensive subjects with low levels of afterload. , 2002, American heart journal.

[13]  G. de Simone,et al.  Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy , 2001, Journal of hypertension.

[14]  P. Okin,et al.  Prognostic implications of left ventricular hypertrophy. , 2001, American heart journal.

[15]  R. Pini,et al.  Measurement of left ventricular mass: methodology and expertise. , 1997, Journal of hypertension.

[16]  G. Reboldi,et al.  Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. , 1995, Journal of the American College of Cardiology.

[17]  D. Levy,et al.  Prognosis of left ventricular geometric patterns in the Framingham Heart Study. , 1995, Journal of the American College of Cardiology.

[18]  D. Levy,et al.  Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. , 1994, JAMA.

[19]  J. Laragh,et al.  Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. , 1994, Hypertension.

[20]  L. Rossi,et al.  Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. , 1994, The American journal of cardiology.

[21]  J. Ghali,et al.  The Prognostic Role of Left Ventricular Hypertrophy in Patients with or without Coronary Artery Disease , 1992, Annals of Internal Medicine.

[22]  J. Laragh,et al.  Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. , 1992, Journal of the American College of Cardiology.

[23]  K. Weber,et al.  Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.

[24]  R. Cooper,et al.  Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. , 1991, Journal of the American College of Cardiology.

[25]  J. Laragh,et al.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.

[26]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[27]  R. Kleiger,et al.  Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial infarction. , 1988, The American journal of cardiology.

[28]  S. Shroff,et al.  Collagen Remodeling of the Pressure‐Overloaded, Hypertrophied Nonhuman Primate Myocardium , 1988, Circulation research.

[29]  H. Dargie,et al.  Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. , 1987, The New England journal of medicine.

[30]  D. Levy,et al.  Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. , 1987, The American journal of cardiology.

[31]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.